Co-Diagnostics Inc (CODX) USD0.001
Co-Diagnostics, Inc. is a molecular diagnostics company. The Company is engaged in developing, manufacturing and selling reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules, including molecular tools for the detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. It also uses its technology to design specific tests for its Co-Dx PCR Home platform and to locate genetic markers for use in applications other than infectious disease. It also sells diagnostic equipment from other manufacturers as self-contained lab systems. The Company is also developing a portable polymerase chain reaction (PCR) device and test cups that are designed to bring PCR to patients in point-of-care and even at-home settings. Its diagnostics systems enable molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.